- Use of Corus® CAD Led to a Statistically Significant Reduction in Additional Cardiac Testing - PR Newswire PALO ALTO, Calif., May 20, 2013... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45676&title=CardioDx-Announces-Publication-of-the-IMPACTCARD-Trial-Demonstrating-Use-of-Corus®-CAD-Test-Influenced-Cardiologistsapos-Clinical-Management-of-Patients-with-Symptoms-Suggestive-of-ObstrucAbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephrop... Abbvie Inc.... ...
http://in.advfn.com/p.php?pid=nmona&article=57648181OrbusNeich's Genous Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment E... HONG KONG, May 20,... ...
http://in.advfn.com/p.php?pid=nmona&article=57641722Verona Pharma (VRP) Quote : 2.475 0.0 (0.00%) @ 9:30AM Verona Pharma (LSE:VRP) Intraday Stock Chart Today : Monday 20 May 2013 20th May 2013 Verona... ...
http://in.advfn.com/p.php?pid=nmona&article=57639124Markers associated with Alzheimer's disease were found to increase linearly with severity of sleep-disordered breathing, say scientists. But this... ...
http://www.medindia.net/news/link-between-sleep-apnea-and-alzheimers-disease-identified-119181-1.htm